MX9202507A - Composicion farmaceutica para el tratamiento de esofagitis de reflujo. - Google Patents

Composicion farmaceutica para el tratamiento de esofagitis de reflujo.

Info

Publication number
MX9202507A
MX9202507A MX9202507A MX9202507A MX9202507A MX 9202507 A MX9202507 A MX 9202507A MX 9202507 A MX9202507 A MX 9202507A MX 9202507 A MX9202507 A MX 9202507A MX 9202507 A MX9202507 A MX 9202507A
Authority
MX
Mexico
Prior art keywords
treatment
pharmaceutical composition
reflux esophagitis
esophagitis
reflux
Prior art date
Application number
MX9202507A
Other languages
English (en)
Spanish (es)
Inventor
Michelle Louise Cloud
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of MX9202507A publication Critical patent/MX9202507A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MX9202507A 1991-05-28 1992-05-27 Composicion farmaceutica para el tratamiento de esofagitis de reflujo. MX9202507A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US70614591A 1991-05-28 1991-05-28

Publications (1)

Publication Number Publication Date
MX9202507A true MX9202507A (es) 1992-11-01

Family

ID=24836392

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9202507A MX9202507A (es) 1991-05-28 1992-05-27 Composicion farmaceutica para el tratamiento de esofagitis de reflujo.

Country Status (10)

Country Link
EP (1) EP0516345A1 (enExample)
JP (1) JPH05148142A (enExample)
KR (1) KR920021144A (enExample)
AU (1) AU1721892A (enExample)
CA (1) CA2069162A1 (enExample)
HU (1) HU9201751D0 (enExample)
MX (1) MX9202507A (enExample)
NO (1) NO922019L (enExample)
TW (1) TW202387B (enExample)
ZA (1) ZA923711B (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8071128B2 (en) 1996-06-14 2011-12-06 Kyowa Hakko Kirin Co., Ltd. Intrabuccally rapidly disintegrating tablet and a production method of the tablets
US9358214B2 (en) 2001-10-04 2016-06-07 Adare Pharmaceuticals, Inc. Timed, sustained release systems for propranolol
US8367111B2 (en) 2002-12-31 2013-02-05 Aptalis Pharmatech, Inc. Extended release dosage forms of propranolol hydrochloride
US8747895B2 (en) 2004-09-13 2014-06-10 Aptalis Pharmatech, Inc. Orally disintegrating tablets of atomoxetine
US9884014B2 (en) 2004-10-12 2018-02-06 Adare Pharmaceuticals, Inc. Taste-masked pharmaceutical compositions
WO2006047493A2 (en) 2004-10-21 2006-05-04 Eurand Pharmaceuticals Limited Taste-masked pharmaceutical compositions with gastrosoluble pore-formers
US9161918B2 (en) 2005-05-02 2015-10-20 Adare Pharmaceuticals, Inc. Timed, pulsatile release systems
DK3354276T3 (da) * 2007-11-13 2020-03-30 Meritage Pharma Inc Sammensætninger til behandlingen af gastrointestinal inflammation
SG10201407965XA (en) 2009-12-02 2015-02-27 Aptalis Pharma Ltd Fexofenadine microcapsules and compositions containing them

Also Published As

Publication number Publication date
NO922019L (no) 1992-11-30
CA2069162A1 (en) 1992-11-29
JPH05148142A (ja) 1993-06-15
NO922019D0 (no) 1992-05-22
AU1721892A (en) 1992-12-03
TW202387B (enExample) 1993-03-21
EP0516345A1 (en) 1992-12-02
KR920021144A (ko) 1992-12-18
ZA923711B (en) 1993-11-22
HU9201751D0 (en) 1992-08-28

Similar Documents

Publication Publication Date Title
FI922958L (fi) Farmaceutisk sammansaettning
FI922252L (fi) Farmaceutisk sammansaettning
FI922316L (fi) Farmaceutisk sammansaettning
FI925615A0 (fi) Stabiliserade farmaceutiska kompositioner, som innehaoller en hmg-coa-reduktas-inhibitorfoerening
MX9204625A (es) Composicion farmaceutica para el tratamiento de una especie de mamifero, que sufre de deficiencia cardiaca congestiva.
MX9204229A (es) Trifluorometilbencilfosfonatos utiles en el tratamiento de osteoporosis.
FI921060A0 (fi) Farmaceutiska aerosolformuleringar.
NL194664B (nl) Farmaceutische samenstelling voor het genezen van tumorachtige ziekten.
FI923581A0 (fi) Farmaceutisk kombinationsformation.
MX9207008A (es) Medicamentos para el tratamiento de condiciones inflamatorias o para la analgesia.
AR244492A1 (es) Composicion fungicida mejorada para el tratamiento de la madera.
MX9200622A (es) Composicion farmaceutica
NO911429L (no) Stoffbehandling.
MX9205637A (es) Metodo para prevenir el rechazo de aloinjertos.
BR9806083A (pt) Composi-Æo farmac-utica para o tratamento da hapattite c
NO911430L (no) Stoffbehandlingsmetode.
MX9201258A (es) Compuestos para el tratamiento del cancer y procedimiento para su preparacion.
MX9204286A (es) Agentes para el tratamiento de semillas.
MX9203208A (es) Composicion farmaceutica y metodo para el tratamiento de trastornos digestivos.
FI920845A0 (fi) Farmaceutiska kompositioner innehaollande interleukin-2.
ES2019583B3 (es) Composicion para el tratamiento de infecciones.
MX9204485A (es) Composicion farmaceutica para el tratamiento de enfermedades inflamatorias.
ES1017890Y (es) Dispositivo para el tratamiento de uneros.
MX9203089A (es) Composicion para el tratamiento de esquisofrenia.
MX9200555A (es) Composicion farmaceutica para la aplicacion topicaterapeutica en el tratamiento de catarata pre-senil y senil.